Records containing: Myasthenia Gravis, Generalized
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a Long-term Extension of Povetacicept in Adults With Generalized Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2026-04-17Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis (gMG) Naive to Complement Inhibitors. Prospective, Multicenter, Non-interventional Study (MG-ARCADIA).
-
CLINICAL_TRIALS study record update · 2026-01-22Unhide® Project Also Known as The Unhide® Solve Together Unified Platform
-
CLINICAL_TRIALS study record update · 2026-01-07Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360
-
CLINICAL_TRIALS study record update · 2025-11-05A Randomized, Double-Blinded, Placebo-Controlled, Phase 3, Parallel-Group Design Study Evaluating the Efficacy and Safety of Efgartigimod IV in Adult Participants With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-11-04Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2025-10-07A Phase 2, Randomized, Blinded, Placebo-Controlled, Study to Evaluate Safety, Tolerability, Pharmacometrics, and Efficacy of DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
-
CLINICAL_TRIALS study record update · 2025-09-24A Multicenter, Prospective, Observational, Open-label Study to Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod
-
CLINICAL_TRIALS study record update · 2025-09-16A Prospective,Single-center,Single-Arm,Single-Blind Pilot Study To Investigate The Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2025-08-01Single-cell Deep Phenotyping of B Lymphocytes to Personalize Immunotherapy in Patients With Myasthenia Gravis: Clinical Trial to Evaluate the Efficacy and Safety of Rituximab in Generalized AChR-antibody Positive Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2025-08-01Identification of Clinical, Biological, Cellular and Genetic Markers of Favorable Response Complement Inhibitors Therapy in Patients With Generalized Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2025-06-05A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2025-05-28Autologous T-Cells Expressing A Chimeric Antigen Receptor Directed To B-Cell Maturation Antigen (BCMA) In Patients With Generalized Myasthenia Gravis (MG)
-
CLINICAL_TRIALS study record update · 2025-05-23A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase III Study of Telitacicept in Patients With Generalized Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2025-05-06A Single-center, Single-arm, Dose-exploration Study Evaluating the Safety and Efficacy of SENL103 Autologous T-cell Injection (S103) in the Treatment of Refractory Generalized Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2025-05-01A Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2025-01-01An Exploratory Study on the Safety and Efficacy of Universal CAR-T Cells Targeting BCMA and CD19 in the Treatment of Refractory Autoimmune Diseases of the Nervous System
-
CLINICAL_TRIALS study record update · 2024-09-27Myasthenia Gravis Foundation of America Global MG Patient Registry
-
CLINICAL_TRIALS study record update · 2024-07-31Predictors and Prognostic Factors of Myasthenia Gravis Outcome
-
CLINICAL_TRIALS study record update · 2024-01-22A Phase III, Open-label Extension Trial of tMG to Evaluate the Safety and Efficacy of Tocilizumab in Subjects With Generalized Myasthenia Gravis (gMG)
-
CLINICAL_TRIALS study record update · 2023-01-17A Phase 3, Multicenter, Randomized, Double Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2022-08-25An Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Eculizumab in Pediatric Patients With Refractory Generalized Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2021-08-13A Randomized, Placebo-control, Parallel Group Study to Evaluate the Effect of Amifampridine Phosphate in Patients With MuSK Antibody Positive Myasthenia Gravis, and a Sample of AChR Antibody Positive Myasthenia Gravis Patients
-
CLINICAL_TRIALS study record update · 2019-07-25A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Preliminarily Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of CFZ533 in Patients With Moderate to Severe Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2019-03-05A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis